Page last updated: 2024-08-18

4-butyrolactone and Cerebral Arterial Diseases

4-butyrolactone has been researched along with Cerebral Arterial Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maher, TJ; Quang, LS; Sadasivan, S	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Cerebral Arterial Diseases

Article	Year
Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion. Annals of the New York Academy of Sciences, 2006, Volume: 1074 Topics: 4-Butyrolactone; Animals; Butylene Glycols; Cerebral Arterial Diseases; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Sprague-Dawley; Sodium Oxybate	2006

Article

Year

Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.

Annals of the New York Academy of Sciences, 2006, Volume: 1074

Topics: 4-Butyrolactone; Animals; Butylene Glycols; Cerebral Arterial Diseases; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Sprague-Dawley; Sodium Oxybate

2006